Registration gives the benefit of site update e-mails and additional information from Takeda on new education materials and events.
ADHD Institute Register
ADHD Institute Logo
Takeda Logo
ADHD Institute Register
Burden of ADHD
Assessment & diagnosis
Disease management
Meetings & events
Publications & expert insights
Home
Home
Burden of ADHD
Burden of ADHD
  • Epidemiology
    • Epidemiology: Age
    • Epidemiology: Gender
    • Presentations of ADHD
    • Comorbidities
  • Aetiology
    • Neurobiology
    • Heritability
    • Environmental risk factors
  • Impact of ADHD
    • Social impact
    • Impact on quality of life
    • Economic impact of ADHD
  • Assessment & diagnosis
    Assessment & diagnosis
  • Symptoms of ADHD
  • Diagnosis
    • ICD-10
  • Assessment
  • Rating scales
  • Disease management
    Disease management
  • Guidelines
    • ADHD Clinical Guidelines
    • CADDRA Guidelines
    • GERMAN guidelines
    • NICE guidelines
    • Spanish guidelines
  • Optimal management of ADHD
  • Transition in ADHD
  • Non-pharmacological therapy
    • Parent-led behavioural intervention
    • Classroom-led behavioural interventions
    • Cognitive behavioural therapy
    • Neurofeedback
    • Psychoeducation
    • Exercise and diet
  • Pharmacological therapy
    • Differential response to treatment
    • Mode of action
    • Mechanism of delivery
    • Pharmacokinetics
    • Adherence to treatment
    • Effect size
  • Meetings & events
    Meetings & events
  • On-demand events
    • Webinar: Adult ADHD and comorbid borderline personality disorder webinar
    • Webinar: Adult ADHD and comorbid substance-use disorder
    • Webinar: Neurobiology of ADHD
    • Webinar: Adult ADHD and comorbid anxiety disorders webinar
    • Webinar: Adult ADHD and comorbid major depressive disorder webinar
    • Webinar: Adult ADHD and comorbid bipolar disorder webinar
  • ADHD Institute meetings
    • Week 1 ‒ ADHD and comorbid mental health conditions across the lifespan
    • Week 2 ‒ ADHD and comorbid mental health conditions across the lifespan
    • Week 3 ‒ ADHD and comorbid mental health conditions across the lifespan
    • Week 4 ‒ ADHD and comorbid mental health conditions across the lifespan
    • Day 1 ‒ Advancing the management of ADHD across the lifespan
    • Day 2 ‒ Advancing the management of ADHD across the lifespan
    • A selection of clinical seminars – advancing the management of ADHD across the lifespan
    • Day 1 – Advancing the science and clinical perspectives of ADHD across the life-course
    • Day 2 – Advancing the science and clinical perspectives of ADHD across the life-course
    • A selection of clinical seminars – Advancing the science and clinical perspectives of ADHD across the life-course
    • Day 1 – Changes, challenges and complexities: ADHD across the life-course
    • Day 2 – Changes, challenges and complexities: ADHD across the life-course
    • A selection of clinical seminars – Changes, challenges and complexities: ADHD across the life-course
  • Congress reports
    • 33rd European Clinical Neuropsychopharmacology (ECNP) Virtual Congress
    • 28th European Congress of Psychiatry (EPA) Virtual Congress
    • UKAAN meeting: Delivering cost-effective services to adults with ADHD
    • Day 1: 5th EUNETHYDIS International Conference on ADHD
    • Day 2: 5th EUNETHYDIS International Conference on ADHD
    • Day 3: 5th EUNETHYDIS International Conference on ADHD
    • Day 4: 5th EUNETHYDIS International Conference on ADHD
    • Day 1: From child to adult disorder
    • Day 2: From child to adult disorder
    • Day 3: From child to adult disorder
    • Day 4: From child to adult disorder
  • Key congresses 2020
  • Publications & expert insights
    Publications & expert insights
  • Publications 2020
    • Publications 2019
  • Expert insight
    • Transition in ADHD by Dr Kuben Naidoo
    • Patient-centred management: every patient is different with unique needs – a Spanish perspective. Part 1: Evaluation
    • Patient-centred management: every patient is different with unique needs – a Spanish perspective. Part 2: Treatment plans for children and adolescents
    • ADHD services in paediatric neurodisability in Sheffield, UK by Dr Val Harpin & Dr Caroline Bleakley
  • Burden of ADHD

    Epidemiology

    Aetiology

    Impact of ADHD

    Interactive module: ADHD across the lifespan

    Video: Persistence of ADHD from childhood to adulthood

    Elearning: Adult ADHD: Burden and diagnosis

    Epidemiology: Age

    Epidemiology: Gender

    Presentations of ADHD

    Comorbidities

    eLearning module: Psychiatric comorbidities

    Animation: Childhood/Adolescent ADHD and the brain

    Neurobiology

    Heritability

    Environmental risk factors

    Animation: Adult ADHD and the brain

    Booklet: ADHD - improving visibility in adults

    Social impact

    Impact on quality of life

    Economic impact of ADHD

    eLearning module: Psychiatric comorbidities

    Interactive module: ADHD across the lifespan

    Assessment & diagnosis

    Symptoms of ADHD

    Diagnosis

    Assessment

    Rating scales

    Video: How do the symptoms of ADHD change across the lifespan?

    Video: Who are the key specialists you collaborate with in your clinical practice?

    Interactive module: Rating scale toolkit

    Interactive module: Rating scale toolkit

    Video: Who are the key specialists you collaborate with in your clinical practice?

    VIDEO: Which other health professionals or non-health professionals involved in your patients’ care do you engage with to help with decision-making?

    ICD-10

    Interactive module: Rating scale toolkit

    Video: How much does the disease presentation of ADHD vary between different patients?

    Video: How much does the disease presentation of ADHD vary between different patients?

    Interactive module: Rating scale toolkit

    Video: Who are the key specialists you collaborate with in your clinical practice?

    Video: How much does the disease presentation of ADHD vary between different patients?

    Video: Who are the key specialists you collaborate with in your clinical practice?

    VIDEO: Which other health professionals or non-health professionals involved in your patients’ care do you engage with to help with decision-making?

    Disease management

    Guidelines

    Optimal management of ADHD

    Transition in ADHD

    Non-pharmacological therapy

    Pharmacological therapy

    eLearning module: Treatment of child, adolescent and adult ADHD

    An interactive guide to the MOA of selected medications used in the treatment of ADHD

    Booklet: 2017/2018 ADHD Guidelines

    ADHD Clinical Guidelines

    CADDRA Guidelines

    GERMAN guidelines

    NICE guidelines

    Spanish guidelines

    eLearning module: Treatment of child, adolescent and adult ADHD

    An interactive guide to the MOA of selected medications used in the treatment of ADHD

    ADHD Clinical Guidelines

    VIDEO: ‘Lost in transition’ in adulthood

    Animation: Childhood/Adolescent ADHD and treatment effects in the brain

    Video: What would you share with your peers about managing children and adolescents with ADHD from your clinical experience?

    Video: Please could you provide some specific examples of goals you have set your patient?

    ADHD Clinical Guidelines

    Parent-led behavioural intervention

    Classroom-led behavioural interventions

    Cognitive behavioural therapy

    Neurofeedback

    Psychoeducation

    Exercise and diet

    An interactive guide to the MOA of selected medications used in the treatment of ADHD

    Interactive module: Understanding effect size

    Differential response to treatment

    Mode of action

    Mechanism of delivery

    Pharmacokinetics

    Adherence to treatment

    Effect size

    Booklet: 2017/2018 ADHD Guidelines

    eLearning module: Treatment of child, adolescent and adult ADHD

    Meetings & events

    On-demand events

    Congress reports

    ADHD Institute meetings

    Key congresses 2020

    On-demand events

    Congress reports

    ADHD Institute meetings

    Webinar: Neurobiology of ADHD

    Webinar: Adult ADHD and comorbid substance-use disorder

    Webinar: Adult ADHD and comorbid borderline personality disorder webinar

    33rd European Clinical Neuropsychopharmacology (ECNP) Virtual Congress

    28th European Congress of Psychiatry (EPA) Virtual Congress

    UKAAN meeting: Delivering cost-effective services to adults with ADHD

    Meetings & events

    On-demand events

    Congress reports

    On-demand events

    ADHD Institute meetings

    Congress reports

    Publications & expert insights

    Publications 2020

    Expert insight

    Publications & expert insights

    Expert insight

    Publications 2019

    Transition in ADHD by Dr Kuben Naidoo

    ADHD services in paediatric neurodisability in Sheffield, UK by Dr Val Harpin & Dr Caroline Bleakley

    Search

    Register

    Contact us

    Privacy notice

    Terms of use

    Takeda in ADHD

    Sitemap

    ADHD and you

  • Home
  • Burden of ADHD
  • Epidemiology
  • Epidemiology: Age
  • Epidemiology: Gender
  • Presentations of ADHD
  • Comorbidities
  • Aetiology
  • Neurobiology
  • Heritability
  • Environmental risk factors
  • Impact of ADHD
  • Social impact
  • Impact on quality of life
  • Economic impact of ADHD
  • Assessment & diagnosis
  • Symptoms of ADHD
  • Diagnosis
  • ICD-10
  • Assessment
  • Rating scales
  • Disease management
  • Guidelines
  • ADHD Clinical Guidelines
  • CADDRA Guidelines
  • GERMAN guidelines
  • NICE guidelines
  • Spanish guidelines
  • Optimal management of ADHD
  • Transition in ADHD
  • Non-pharmacological therapy
  • Parent-led intervention
  • Classroom-led interventions
  • Cognitive behavioural therapy
  • Neurofeedback
  • Psychoeducation
  • Exercise and diet
  • Pharmacological therapy
  • Differential response
  • Mode of action
  • Mechanism of delivery
  • Pharmacokinetics
  • Adherence to treatment
  • Effect size
  • Meetings & events
  • On-demand events
  • Webinar: Adult ADHD and comorbid borderline personality disorder webinar
  • Webinar: Adult ADHD and comorbid substance-use disorder
  • Neurobiology of ADHD
  • Webinar: Adult ADHD and comorbid anxiety disorders webinar
  • Webinar: Adult ADHD and comorbid major depressive disorder webinar
  • Webinar: Adult ADHD and comorbid bipolar disorder webinar
  • Congress reports
  • 33rd European Clinical Neuropsychopharmacology (ECNP) Virtual Congress
  • 28th European Congress of Psychiatry (EPA) Virtual Congress
  • UKAAN meeting: Delivering cost-effective services to adults with ADHD
  • Day 1: 5th EUNETHYDIS International Conference on ADHD
  • Day 2: 5th EUNETHYDIS International Conference on ADHD
  • Day 3: 5th EUNETHYDIS International Conference on ADHD
  • Day 4: 5th EUNETHYDIS International Conference on ADHD
  • Day 1: From child to adult disorder
  • Day 2: From child to adult disorder
  • Day 3: From child to adult disorder
  • Day 4: From child to adult disorder
  • ADHD Institute meetings
  • Week 1 ‒ ADHD and comorbid mental health conditions across the lifespan
  • Week 2 ‒ ADHD and comorbid mental health conditions across the lifespan
  • Week 3 ‒ ADHD and comorbid mental health conditions across the lifespan
  • Week 4 ‒ ADHD and comorbid mental health conditions across the lifespan
  • Day 1 ‒ Advancing the management of ADHD across the lifespan
  • Day 2 ‒ Advancing the management of ADHD across the lifespan
  • A selection of clinical seminars – advancing the management of ADHD across the lifespan
  • Day 1 – Advancing the science and clinical perspectives of ADHD across the life-course
  • Day 2 – Advancing the science and clinical perspectives of ADHD across the life-course
  • A selection of clinical seminars – Advancing the science and clinical perspectives of ADHD across the life-course
  • Day 1 – Changes, challenges and complexities: ADHD across the life-course
  • Day 2 – Changes, challenges and complexities: ADHD across the life-course
  • A selection of clinical seminars – Changes, challenges and complexities: ADHD across the life-course
  • Key congresses 2020
  • Publications & expert insights
  • Publications 2020
  • Publications 2019
  • Expert insight
  • Transition in ADHD by Dr Kuben Naidoo
  • Patient-centred management: Part 1: Evaluation
  • Patient-centred management: Part 2: Treatment plans for children and adolescents
  • ADHD services in paediatric neurodisability in Sheffield, UK by Dr Val Harpin & Dr Caroline Bleakley
  • Facebook Google LinkedIn Pinterest Twitter

    ADHD services in paediatric neurodisability in Sheffield, UK

    Home | Burden |
    Takeda Logo
    • Burden of ADHD
    • Assessment & diagnosis
    • Disease management
    • Meetings & events
    • Publications & expert insights
    • Takeda in ADHD
    • Contact us
    • Terms of use
    • Privacy notice
    • Sitemap

    Registration

    Registration gives the benefit of site update e-mails and additional information from Takeda on new education materials and events.
    Copyright © 2021 Takeda Pharmaceutical Company Limited. All rights reserved
    Takeda and the Takeda Logo are registered trademarks of Takeda Pharmaceutical and Company Limited.
    All trademarks are the property of their respective owners
    This website is intended for healthcare professionals outside the US only.
    Site last updated: December 2020 - Main website content job code: INTSP/C-ANPROM/NBU/16/0049
    The site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to our use of cookies as set out in our privacy notice. Please read our privacy notice for more information on the cookies we use and how to delete or block the use of cookies.ContinuePrivacy notice

    ADHD Institue logo

    You’re now being transferred to

    and are leaving the ADHD Institute site

    Takeda has no influence or control over the content of this third party website.

    Continue Cancel